Live feed
Filing
SC 13G/A
SC 13G/A0001422849-24-000023·Capital World Investors
Schedule 13G ownership disclosure
VERTEX PHARMACEUTICALS INC COM
Security class unavailable · CUSIP: 92532F100
Event date: 2024-03-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 25,902,938
- Percent of class
- 10.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001422849-24-000023
- Form type
- SC 13G/A
- Filer
- Capital World Investors
- CIK
- CIK 1422849
- Filed
- Apr 10, 2024
- Reporting period
- Mar 29, 2024
- Description
- Schedule 13G beneficial ownership